Navigation Links
CVA and CVA for CELL-DYN Linearity Control Kits

ProductsCVA and CVA for CELL-DYN Linearity Control Kits
Company Streck
Item CVA and CVA for CELL-DYN Linearity Control Kits
Features 
Description CVA and CVA for CELL-DYN are assayed linearity control kits that are used to assess calibration and to verify patient reportable range of three- and five-part hematology instruments. The kits also measure the linear performance of the analyzer. CVA and CVA for CELL-DYN kits have customized ranges appropriate for each instrument model and provide instrument-specific assay values for the WBC, Platelet, RBC and Hemoglobin parameters. WBC and Platelet parameters have extended ranges providing values up to 410,000 and 3.5 million, respectively. Customers are able to submit their data to Streck for a free calibration verification and linearity report. Open-vial stability is 5 days and closed-vial stability is 120 days. All kits include WBC, PLT and RBC/Hgb vials unless otherwise noted.
Info Streck
Customer Service: (800) 228-6090
Web site: http://www.streck.com/default.asp

Related medicine products :

1. CELL-DYN SlideMaker/Stainer
2. CELL-DYN 1700
3. CELL-DYN 3200
4. CELL-DYN 1800
5. CELL-DYN 3700
6. CELL-DYN 4000
7. CELL-DYN Sapphire
8. CELL-DYN 1700 - Recertified
9. CELL-DYN 3200 - Recertified
10. Lyphochek Hemoglobin A1C Linearity Set
11. Microalbumin Linearity Control
RNA1c Control for Bayer DCA 2000 and 2000 + Analyzers
Molteno3 Glaucoma Drainage Device
...s a reagent and probe system used together to quan...t plate based system is a sandwich nucleic acid hy...for RNA detection and quantification, by amplifyin...chnology. Branched DNA allows immediate quantifica...
Cormet Hip Resurfacing System
Medicine Products:
(Date:11/8/2009)...8 Pharmaceutical Resear...e President Ken Johnson released the following sta...: ,, "We are disappointed, but not surprised by...of hardworking Americans as well as nearly half of...who voted against the bill. ,, "While well inte...
(Date:11/8/2009)... Shows Who Sides With Working Families vs. Insuran...swire-USNewswire/ -- On the heels of an historic l... a good, balanced health care reform bill, the Pen...state,s U.S. representatives voted on HR 3962, the...e legislation, which passed Saturday evening by a ...
(Date:11/7/2009)...v. 7 Speaker Nancy Pel....R. 3962, the Affordable Health Care for America A...tonight. Below are the Speaker,s remarks. ,, ...ric moment for our nation and for American familie...nd political philosophy -- as far back as Teddy Ro...
(Date:11/7/2009)...PRNewswire/ -- Calling this a "defining moment" fo...President J. James Rohack, M.D., today addressed m...te and medical specialty societies at the opening ...ere health system reform will top the agenda. ,...81209/AMALOGO ) ,, "Over the next 72 hours, t...
(Date:11/7/2009)...7 The U.S. bishops Nove...es to vote for the Stupak-Ellsworth Amendment to t...-Pitts-Kaptur-Dahlkemper-Lipinski-Smith Amendment ... funding and conscience protections in the Afforda... said. ,, The letter was signed by Cardinal Jus...
Breaking Medicine News(10 mins):Health News:PhRMA Statement on House Passage of Health Care Reform Bill 2Health News:PhRMA Statement on House Passage of Health Care Reform Bill 3Health News:Robert Brady (D-PA-1), Chaka Fattah (D-PA-2), Kathy Dahlkemper (D-PA-3), Joe Sestak (D-PA-7), Patrick Murphy (D-PA-8), Christopher Carney (D-PA-10), John Murtha (D-PA-12), Paul Kanjorski (D-PA-11), Allyson Schwartz (D-PA-13), Mike Doyle (D-PA-14) Ge 2Health News:Pelosi: Health Legislation Founded on Key Principles for a Healthier America: Innovation, Competition and Prevention 2Health News:Pelosi: Health Legislation Founded on Key Principles for a Healthier America: Innovation, Competition and Prevention 3Health News:Pelosi: Health Legislation Founded on Key Principles for a Healthier America: Innovation, Competition and Prevention 4Health News:AMA President Kicks Off AMA Meeting Focused on Health Reform 2Health News:Bishops Urge Passage of Stupak-Ellsworth Anti-Abortion Amendment for Health Reform Bill 2
...Alseres Pharmaceuticals, Inc. today announced that...ASDAQ Stock Market ("NASDAQ") that for the last 10... listed securities has been below the minimum $35 ...NASDAQ Marketplace Rule 4310(c)(3)(A) or 4310(c)(3...
...scular group practice to use Sage Intergy solution...ition itself for pay-for-performance , , TAMPA, F...scular Institute, a Saginaw-Mich.-based group prac...(PM) and Sage Intergy EHR electronic health reco...
...eveal targets for future treatments , , MO...they have discovered genes in prostate cancer cell...th each other, an occurrence that may initiate the...cer cells, a finding that may serve as a marker fo...
...an Inc. (Nasdaq: MYL ),today announced that its ...onal U.S. patents protecting the company,s Perforo... pulmonary disease (COPD) treatment. , U.S. Pa...ormoterol. This patent covers Dey,s Perforomist(R)...
...publication of its kind aimed at healthcare fraud ...e Insight(R) (HCI), a Verisk HealthCare company an... and overpayment prevention solutions for healthca...lication dedicated to helping public and private s...
... Boehringer Ingelheim today announced the appoint...Sales and Marketing for the company,s Prescription...ad the U.S. sales and marketing strategy of Boehri...ef Executive Officer, Boehringer Ingelheim Corpora...
Other Medicine News:Health News:Alseres Pharmaceuticals, Inc. Receives Notice of Non-Compliance with Continued Listing Requirements 2Health News:Alseres Pharmaceuticals, Inc. Receives Notice of Non-Compliance with Continued Listing Requirements 3Health News:Alseres Pharmaceuticals, Inc. Receives Notice of Non-Compliance with Continued Listing Requirements 4Health News:Michigan CardioVascular Institute Selects Sage Intergy EHR to Streamline Clinical, Workflow and Reporting Efficiencies 2Health News:Michigan CardioVascular Institute Selects Sage Intergy EHR to Streamline Clinical, Workflow and Reporting Efficiencies 3Health News:Michigan CardioVascular Institute Selects Sage Intergy EHR to Streamline Clinical, Workflow and Reporting Efficiencies 4Health News:Michigan CardioVascular Institute Selects Sage Intergy EHR to Streamline Clinical, Workflow and Reporting Efficiencies 5Health News:U.S. Patent and Trademark Office Issues Mylan's Specialty Division, Dey L.P., Three Additional Patents Protecting Perforomist(R) Inhalation Solution 2Health News:HealthCare Insight(R) Launches Industry Fraud Magazine 2Health News:Boehringer Ingelheim Appoints Albert Ros as Executive Vice President of Sales and Marketing for Prescription Medicines 2
(Date:11/6/2009)..., Nov. 6 Caraco Pharmace...aunched ketorolac tromethamine ophthalmic solution... and Drug Administration (FDA) for Sun Pharma,s Ab...Acular® opthalmic solution on the first day f...olac is therapeutically equivalent to Acular®...
(Date:11/6/2009)...IS, November 6 , - Trial ...lid for the,Treatment of Multi-Resistant Staphyloc... a speciality pharmaceutical company focused on th...esigned to overcome the significant global,problem... most advanced oral,antibacterial NXL103 (floprist...
(Date:11/5/2009)...GO, Nov. 5 Althea Technologies, I...turing services for biopharmaceutical products ann...lopment to the company,s platform of services, whi...es Matsuura, Director of Formulation Development. ...ion and analytical scientists, along with new labo...
Breaking Medicine Technology:Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Acular(R) Opthalmic Solution 2Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI) 2Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI) 3Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI) 4Althea Technologies Adds Formulation Development to Its Integrated Offering of Contract Services 2Oncothyreon announces initiation of Phase 3 trial of Stimuvax in breast cancer 12721 1Oncothyreon announces initiation of Phase 3 trial of Stimuvax in breast cancer 12721 2Oncothyreon announces initiation of Phase 3 trial of Stimuvax in breast cancer 12721 3Oncothyreon announces initiation of Phase 3 trial of Stimuvax in breast cancer 12721 4Geographic profiling applied to track hunting patterns of white sharks in South Africa 8945 1Geographic profiling applied to track hunting patterns of white sharks in South Africa 8945 2Iran Blocks Access to the Chopra Center 26apos 3Bs Web Site Podcasts and Blogs 49586 1Iran Blocks Access to the Chopra Center 26apos 3Bs Web Site Podcasts and Blogs 49586 2Iran Blocks Access to the Chopra Center 26apos 3Bs Web Site Podcasts and Blogs 49586 3